Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Aspirin vs Placebo in the Prevention of Recurrent Spontaneous Preterm Labor
NCT07745595Not yet recruiting
- Sponsor
- University of Health Sciences Lahore
- Start
- Aug 2026
- Primary completion
- Feb 2027
01
Overview
Randomised, double-blind trial in Preterm labor (PTL) comparing Group-I: Aspirin Group with Group-II: Placebo Group (2 arms). Primary endpoint: Incidence of Recurrent Spontaneous Preterm Labor up to 42 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT07745595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07745595.